








Richard J. Meelia - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Richard J. Meelia
Former Board Member at Haemonetics Corporation


View Full Profile
Are you Richard J. Meelia? Claim your profile


 


Sign up for Equilar Atlas and view Richard J. Meelia's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Richard J. Meelia's  network and community.
												FOLLOW changes in Richard J. Meelia's employment and money-in-motion.
												CONNECT with Richard J. Meelia through your network of contacts.
												








Richard J. Meelia's Executive Work History


Past
To view Richard J. Meelia's complete executive work history, sign up now
Age
68

 
 


Richard J. Meelia's Biography



Having served as President and Chief Executive Officer of one of the world's largest global healthcare products companies and having a long and decorated career in the healthcare industry, Mr. Meelia provides the Board many years of leadership experience in the global healthcare industry, including expertise in strategic planning, market development and international operations.


Mr. Meelia, 68, joined the Board of Directors and assumed the role of Chairman in 2011. Mr. Meelia is currently a principal of Meelia Ventures, LLC, a private equity firm focused on early stage healthcare companies. Mr. Meelia is also currently a member of the Bo ...
(Read More)

			Having served as President and Chief Executive Officer of one of the world's largest global healthcare products companies and having a long and decorated career in the healthcare industry, Mr. Meelia provides the Board many years of leadership experience in the global healthcare industry, including expertise in strategic planning, market development and international operations.


Mr. Meelia, 68, joined the Board of Directors and assumed the role of Chairman in 2011. Mr. Meelia is currently a principal of Meelia Ventures, LLC, a private equity firm focused on early stage healthcare companies. Mr. Meelia is also currently a member of the Board of Trustees of St. Anselm College. He also currently serves as a member of the Board of Directors of ConforMIS Inc., a medical technology company focused on custom joint replacements and as the Chairman of the Board of Apollo Endosurgery, Inc., a public company focused on the development of devices that advance therapeutic endoscopy.


From July 2007 until his retirement in July 2011, Mr. Meelia served as Chairman, President, and Chief Executive Officer of Covidien plc following its separation from Tyco International in June 2007. From January 2006 through the separation, Mr. Meelia was the Chief Executive Officer of Tyco Healthcare, and from 1995 through the separation, Mr. Meelia was also the President of Tyco Healthcare. Mr. Meelia joined Kendall Healthcare Products Company, the foundation of both the Tyco Healthcare Business and Covidien, as Group President in 1991. He became President of Tyco Healthcare in 1995. Mr. Meelia formerly served on the Haemonetics Board from 2005 to 2009. He resigned to focus on his responsibilities as Chief Executive Officer at Covidien. Early in his career, Mr. Meelia was promoted through a series of sales and marketing positions at the Pharmaseal and McGaw divisions of American Hospital Supply, where he ultimately became Vice President of Sales and Marketing. Following his career at American Hospital Supply, and before joining Kendall Healthcare, Mr. Meelia was President of Infusaid, Inc., a $30 million division of Pfizer that marketed implantable infusion pumps and ports.


Other Public Company Board Service: ConforMIS Inc. (NASDAQ: CFMS); Apollo Endosurgery, Inc., (NASDAQ: APEN)
		
Source: Haemonetics Corporation on 06/12/2017
		
	

 






Sign up for Equilar Atlas and view Richard J. Meelia's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Richard J. Meelia. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Richard J. Meelia's  network and community.
												FOLLOW changes in Richard J. Meelia's employment and money-in-motion.
												CONNECT with Richard J. Meelia through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Richard J. Meelia


















Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









Jan Koum
Board Member, Facebook, Inc.









Philip L. Milstein
Board Member, The Marcus Corporation












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993















Richard J. Meelia: Executive Profile & Biography - Bloomberg









































  





















































































July 22, 2017 12:47 PM ET
Personal Products

Company Overview of Tyco Healthcare Retail Group, Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Richard J. Meelia  Chief Executive Officer, Tyco Healthcare Retail Group, Inc.AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 10 different industries.See Board Relationships68--
Background

		Mr. Richard J. Meelia, also known as Rich, serves as a Principal of Meelia Ventures, LLC. Mr. Meelia has been Executive Officer of Power Medical Interventions, Inc. since September 2009. He serves as Associate of Kairos Partners L.P. He served as the President of Infusaid, Inc. He served as the Chief Executive Officer and President of Covidien Ltd. from January 2006 to July 1, 2011. He served as the President of Covidien Inc. from 1995 to July 1, 2011. From July 2007 ... to July 2011, he served as President and Chief Executive Officer of Covidien plc. From January 1991 to January 1995, Mr. Meelia served as the Group President of Kendall Healthcare Products Company. He served as Chief Executive Officer at Tyco Healthcare Retail Group, Inc. He served as the Chief Executive Officer of Tyco Healthcare since June 2006 and President of Tyco Healthcare and Specialty Product of Tyco International Ltd. since 1995. He served as Chairman of Covidien Plc, Chief Executive Officer of Covidien Plc and President of Covidien Plc at Nellcor Puritan Bennett LLC. He served as Vice President of Tyco International Ltd. since June 2000. He has been the Chairman of Haemonetics Corporation since June 3, 2011 and its Independent Director since June 3, 2016. He serves as Chairman of Apollo Endosurgery, Inc. and has been its Director since July 2012. He serves as a Director of Triangle, Inc. He has been a Director of ConforMIS, Inc. since June 2015. He serves as a Director of Mallinckrodt LLC. He also serves on the Board of Governors of the Tufts-New England Medical Center and the Board of Trustees of St. Anselm College. He is member of several charitable boards, including Tufts Medical Center. He served as the Chairman of Covidien Plc from October 2008 to March 13, 2012. He served as a Director of Aspect Medical Systems, Inc. from 2001 to September 23, 2005. He served as a Director of VASAMED, Inc. since June 1997 and Covidien plc since June 2007. He served as an Independent Director of Haemonetics Corporation from July 27, 2005 to 2008. He has a Bachelor's Degree from Saint Anselm College. Mr. Meelia earned an MBA degree from Boston College.Read Full Background




Corporate Headquarters
601 Allendale RoadKing of Prussia, Pennsylvania 19406United StatesPhone: 610-265-5000Fax: 610-878-3486
Board Members Memberships
Director, President of Covidien Ltd and Chief Executive Officer of Covidien LtdMallinckrodt LLC2011-PresentChairmanHaemonetics Corporation2012-PresentChairmanApollo Endosurgery, Inc.2015-PresentDirectorConforMIS, Inc.
Education
MBA Boston CollegeBA Saint Anselm College
Other Affiliations
Mallinckrodt LLCAspect Medical Systems, Inc.Kendall International, Inc.VASAMED, Inc.Haemonetics CorporationTyco International plcNellcor Puritan Bennett LLCPower Medical Interventions, Inc.Boston CollegeSaint Anselm CollegeConforMIS, Inc.Kairos Partners, L.P.Covidien plcCovidien International Finance S.A.Apollo Endosurgery, Inc.Covidien Holding Inc.Meelia Ventures, Llc


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
				There is no Total Compensation data available.
			



Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Tyco Healthcare Retail Group, Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close




























Richard J. Meelia: Executive Profile & Biography - Bloomberg









































  





















































































July 22, 2017 12:47 PM ET
Personal Products

Company Overview of Tyco Healthcare Retail Group, Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Richard J. Meelia  Chief Executive Officer, Tyco Healthcare Retail Group, Inc.AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 10 different industries.See Board Relationships68--
Background

		Mr. Richard J. Meelia, also known as Rich, serves as a Principal of Meelia Ventures, LLC. Mr. Meelia has been Executive Officer of Power Medical Interventions, Inc. since September 2009. He serves as Associate of Kairos Partners L.P. He served as the President of Infusaid, Inc. He served as the Chief Executive Officer and President of Covidien Ltd. from January 2006 to July 1, 2011. He served as the President of Covidien Inc. from 1995 to July 1, 2011. From July 2007 ... to July 2011, he served as President and Chief Executive Officer of Covidien plc. From January 1991 to January 1995, Mr. Meelia served as the Group President of Kendall Healthcare Products Company. He served as Chief Executive Officer at Tyco Healthcare Retail Group, Inc. He served as the Chief Executive Officer of Tyco Healthcare since June 2006 and President of Tyco Healthcare and Specialty Product of Tyco International Ltd. since 1995. He served as Chairman of Covidien Plc, Chief Executive Officer of Covidien Plc and President of Covidien Plc at Nellcor Puritan Bennett LLC. He served as Vice President of Tyco International Ltd. since June 2000. He has been the Chairman of Haemonetics Corporation since June 3, 2011 and its Independent Director since June 3, 2016. He serves as Chairman of Apollo Endosurgery, Inc. and has been its Director since July 2012. He serves as a Director of Triangle, Inc. He has been a Director of ConforMIS, Inc. since June 2015. He serves as a Director of Mallinckrodt LLC. He also serves on the Board of Governors of the Tufts-New England Medical Center and the Board of Trustees of St. Anselm College. He is member of several charitable boards, including Tufts Medical Center. He served as the Chairman of Covidien Plc from October 2008 to March 13, 2012. He served as a Director of Aspect Medical Systems, Inc. from 2001 to September 23, 2005. He served as a Director of VASAMED, Inc. since June 1997 and Covidien plc since June 2007. He served as an Independent Director of Haemonetics Corporation from July 27, 2005 to 2008. He has a Bachelor's Degree from Saint Anselm College. Mr. Meelia earned an MBA degree from Boston College.Read Full Background




Corporate Headquarters
601 Allendale RoadKing of Prussia, Pennsylvania 19406United StatesPhone: 610-265-5000Fax: 610-878-3486
Board Members Memberships
Director, President of Covidien Ltd and Chief Executive Officer of Covidien LtdMallinckrodt LLC2011-PresentChairmanHaemonetics Corporation2012-PresentChairmanApollo Endosurgery, Inc.2015-PresentDirectorConforMIS, Inc.
Education
MBA Boston CollegeBA Saint Anselm College
Other Affiliations
Mallinckrodt LLCAspect Medical Systems, Inc.Kendall International, Inc.VASAMED, Inc.Haemonetics CorporationTyco International plcNellcor Puritan Bennett LLCPower Medical Interventions, Inc.Boston CollegeSaint Anselm CollegeConforMIS, Inc.Kairos Partners, L.P.Covidien plcCovidien International Finance S.A.Apollo Endosurgery, Inc.Covidien Holding Inc.Meelia Ventures, Llc


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
				There is no Total Compensation data available.
			



Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Tyco Healthcare Retail Group, Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close


























Request unsuccessful. Incapsula incident ID: 574000390082440076-124262543601304181Request unsuccessful. Incapsula incident ID: 574000390082440076-98051943036748404Request unsuccessful. Incapsula incident ID: 574000390082440076-258373215246484090   Richard Meelia | Covidien Ltd. | ZoomInfo.com




















 



 Richard J. Meelia Elected Chairman of Haemonetics Board of Directors 
         










    










 






 











 









Richard J. Meelia Elected Chairman of Haemonetics Board of Directors

Jun 06, 2011, 08:00 ET
		  		  									
						 from   Haemonetics Corporation 











 
















































 

 




















 


BRAINTREE, Mass., June 6, 2011 /PRNewswire/ -- Haemonetics Corporation (NYSE:   HAE) announced today that its Board of Directors elected Rich Meelia to join the Board and assume the role of Chairman, effective immediately.  Meelia, 62, will retire as Covidien plc's President and Chief Executive Officer on July 1, 2011. He will remain as Non-Executive Chairman of Covidien.  Prior to serving as Covidien's Chief Executive Officer, Meelia was President and Chief Executive Officer of Tyco Healthcare and President of Kendal Healthcare Products Company, the foundation of both the Tyco Healthcare business and Covidien. 
Mr. Meelia, who has close to 40 years of healthcare industry experience, formerly served on the Haemonetics Board from 2005-2009. He resigned to focus on his CEO responsibilities at Covidien. Early in his career, he was promoted through a series of sales and marketing positions at the Pharmaseal and McGaw divisions of American Hospital Supply, where he ultimately became Vice President of Sales and Marketing.  Following his career at American Hospital Supply, and before joining Kendal Healthcare, Mr. Meelia was President of Infusaid, Inc. a $30 million division of Pfizer that marketed implantable infusion pumps and ports.
Brian Concannon, Haemonetics' President and Chief Executive Officer said, "Rich's exceptional leadership, proven record of driving transformational change in healthcare, and his past experience at Haemonetics makes him the ideal person to lead our Board during this important time in our history."
"I look forward to rejoining the Haemonetics Board of Directors and serving the Company's shareholders," said Mr. Meelia. "Brian and his team have done a terrific job in growing the business and I believe Haemonetics is well-positioned to succeed going forward."  
Haemonetics (NYSE:   HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers.  Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world.  Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services.  To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.
CONTACT:
Bryanne Salmon
Tel. (781) 356-9613
Alt. (617) 633-2297
bsalmon@haemonetics.com
 SOURCE  Haemonetics Corporation  

RELATED LINKS
http://www.haemonetics.com



  

 View Table Fullscreen 




  View Table Fullscreen 





Journalists and Bloggers
The news you need, when you need it.
 
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.
LEARN MORE




 

 
 



















































  











Jul 11, 2011, 16:00 ET
Preview: Haemonetics Sets Date for First Quarter Fiscal Year 2012 Earnings Release: August 1, 2011













May 02, 2011, 08:00 ET
Preview: Haemonetics Reports 15% Growth in Adjusted EPS to $3.27 for Fiscal 2011






My News


  Release contains wide tables.	  View fullscreen.






 Read More











Jun 14, 2017, 16:00 ET
Haemonetics Sets Date for Publishing 1st Quarter Fiscal 2018...














Jun 14, 2017, 16:00 ET
Haemonetics Announces Formation of Scientific Advisory Council














Jun 14, 2017, 16:00 ET
Haemonetics Will Webcast Investor and Analyst Meeting











Looking to send a news release with PR Newswire?
Take advantage of the world's leading distribution platform.
Sign up to get started
Request more information
Have an account? Log In

 















Search











Searching for your content...









Advanced Search












































 


 



The Covidien Story: Commitment to Innovation, New Ideas and Technology - MIT Enterprise Forum of Cambridge


















































 

 
 














Follow us Login
 












				Posted on   by mitefcmb 


Directions / Parking Information



 « All Events


This event has passed.
The Covidien Story: Commitment to Innovation, New Ideas and Technology

December 8, 2010 at  6:00 PM - 9:00 PM $45




Event Navigation

« Concept Clinic with Oxalys Pharmaceuticals
Near Field Communication (NFC): The RFID Revolution for your Mobile Phone — e-Wallets and much more »








Featuring  Richard J. Meelia, Chairman, President and CEO, Covidien
For Covidien, it’s a new era with nothing but promise. After separating from Tyco International in 2007, Covidien is now a $10 billion, 43,000 employee global healthcare products leader dedicated to innovation and long-term growth.
How has Covidien reached these new heights? CEO Richard Meelia will share his story on how this Massachusetts based company has become a market leader through increased research and development, targeted acquisitions and an enhanced global infrastructure, including sales, marketing and distribution.
Following Richard Meelia there will be a medtech investor panel discussing start-up strategies and the potential acquisition by companies like Covidien.
•	Is the end-game strategy of acquisition a good idea for medtech companies?
•	What are large medtech companies seeking in an acquisition?
•	How can entrepreneurs best prepare, promote and position their technology for an acquisition strategy?
Panelists:
John L. Brooks,  CEO of Reflectance Medical, a noninvasive tissue perfusion company.
John also manages Healthcare Capital Consulting LLC, an advisory services and consulting firm that consults with life science companies, especially early stage start-ups that are seeking strategic advice as well as access to capital to initiate, develop and grow their businesses.
Ed Cahill, Partner, HLM Venture Partners, which provides venture capital to emerging companies focused on health care information technology, health care services and medical devices.
Jed Cohen, Managing Director, Investment Banking, Medical Devices of Leerink Swann, an investment bank to both emerging and established healthcare companies.
 Jonathan (Johnny) Reis, Founder & Managing Partner of Extera Partners, a global life sciences management firm that specializes in corporate and business development, product commercialization in Europe and the US, and company turnarounds.
Moderated by:
Richard 							B. 							Smith, Partner, Edwards Angell Palmer & Dodge
Rich counsels medtech companies on corporate issues including mergers and acquisitions, corporate formation, venture capital and other financing, joint ventures, university licensing and intellectual property strategies.


+ Google Calendar+ iCal Export



 Details 

 Date: 

 December 8, 2010 

 Time: 


					6:00 PM - 9:00 PM				

 Cost: 
 $45 
Event Category: Innovation Series



 Venue 

  
 Phone: 
 617-253-8240 



 



Event Navigation

« Concept Clinic with Oxalys Pharmaceuticals
Near Field Communication (NFC): The RFID Revolution for your Mobile Phone — e-Wallets and much more »





Please note that we ask that you give us 24 hours notice if you wish to cancel your registration. We will not issue refunds with less than 24 hours notice.
Need to cancel a registration? Contact us.












































403 - Forbidden: Access is denied.



Server Error


403 - Forbidden: Access is denied.
You do not have permission to view this directory or page using the credentials that you supplied.




